The human OGG1 gene encodes a DNA glycosylase activity catalysing the excision of the mutagenic lesion 7,8-dihydro-8-oxoguanine from oxidatively damaged DNA. The OGG1 gene was localized to chromosome 3p25, a region showing frequent loss of heterozygosity (LOH) in lung and kidney tumours. In this study, we have analysed by RT ± PCR the expression of OGG1 in 25 small cell lung cancers, in 15 kidney carcinomas and the 15 normal kidney counterparts. The results show that OGG1 messenger RNA can be detected in all tumours tested and that no signi®cant dierence was observed in the level of expression between normal and tumoral kidney tissues. Denaturing gradient gel electrophoresis (DGGE) was used to screen this series of human tumours for alterations in the OGG1 cDNA. The study revealed homozygous mutations in three tumours, two from lung and one from kidney. Sequencing analysis of the mutants identi®ed a single base substitution in each of the three cases: two tranversions (GC to TA and TA to AT) and one transition (GC to AT). All three substitutions cause an amino acid change in the hOgg1 protein. For the mutant kidney tumour, the normal tissue counterpart shows a wild-type pro®le. These results suggest a role for OGG1 mutations in the course of the multistage process of carcinogenesis in lung or kidney.
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Keywords: oxidative DNA damage; DNA repair; missense mutations of OGG1 gene; human lung and kidney cancer; tumour suppressor gene Damage to DNA by oxygen-free radicals is postulated to cause mutations that are associated with the initiation or the progression of human cancers (Breimer, 1990; Loeb, 1997; Beckman and Ames, 1997) . Oxidative damage-induced mutations can activate oncogenes or inactivate tumour suppressor genes altering the cell growth control (Fearon, 1997 ). An oxidatively damaged guanine, 7, , is abundantly produced in DNA as a consequence of the cellular oxidative metabolism or the exposure to ionizing radiation or chemical carcinogens (Dizdaroglu, 1991; Cadet et al., 1997) . The presence of 8-OxoG in DNA has been shown to be mutagenic since, while this lesion does not impede DNA chain elongation, it preferentially pairs with adenine during in vitro DNA synthesis (Shibutani et al., 1991) . The biological incidence of the presence of 8-OxoG in DNA has been unveiled by the study of two genes in E. coli, fpg (mutM) and mutY (micA) which code for DNA glycosylases that cooperate to prevent the mutagenic eects of 8-OxoG in DNA (Boiteux et al., 1987; Cabrera et al., 1988; Radicella et al., 1988; Nghiem et al., 1988; Au et al., 1989) . Inactivation of either gene leads to a spontaneous mutator phenotype characterized by the exclusive increase in GC to TA transversions (Michaels and Miller, 1992; Grollman and Moriya, 1993; Boiteux and Laval, 1997) . In Saccharomyces cerevisiae the OGG1 gene was cloned as the functional eukaryotic homologue of the bacterial fpg gene (Auret van der Kemp et al., 1996) . The yeast Ogg1 protein is a DNA glycosylase/AP lyase which excises 8-OxoG, formamidopyrimidines and incizes apurinic/apyrimidinic (AP) sites in damaged DNA (Auret van der Kemp et al., 1996; Nash et al., 1996; Girard et al., 1997; Karahalil et al., 1998) . Furthermore, inactivation of the OGG1 gene in yeast creates a mutator phenotype that is also speci®c for the generation of the GC to TA transversions (Thomas et al., 1997) . The presence of a similar system in mammals has been established by the recent cloning of the human and mouse OGG1 cDNAs (Lu et al., 1997; Arai et al., 1997; Abarutani et al., 1997; Rosenquist et al., 1997; Radicella et al., 1997; Roldan-Arjona et al., 1997; Bjoras et al., 1997) . At least two messenger RNA forms have been identi®ed in human cells, coding for proteins of 345 and 424 amino acids with molecular weights of 39-kDa and 47-kDa, respectively (Lu et al., 1997; Arai et al., 1997; Abarutani et al., 1997; Rosenquist et al., 1997; Radicella et al., 1997; Roldan-Arjona et al., 1997; Bjoras et al., 1997) . The biological signi®cance of this polymorphism has not yet been elucidated. However, the 39-kDa form of hOgg1 protein, refered as the a-form, seems to be the most abundant and is localized in the nucleus (Bjoras et al., 1997; Boiteux and Radicella, 1998) . The a-hOgg1 protein is an 8-OxoG DNA glycosylase/AP lyase that complements the mutator phenotype of the ogg1 mutants of S. cerevisiae (Radicella et al., 1997) . By analogy with the yeast system, inactivation of the OGG1 gene in human cells could lead to a mutator phenotype due to unrepaired 8-OxoG in DNA.
It has been proposed that a mutator phenotype might be involved at some point in this multistage process of carcinogenesis (Loeb, 1991) . This model has been actually con®rmed by the ®nding that the hereditary nonpolyposis colorectal cancer (HNPCC) is associated with defects in genes coding for homologues of the bacterial mismatch repair proteins MutS or MutL (Fishel et al., 1993; Leach et al., 1993; Parsons et al., 1993; Jiricny, 1994; Edelman et al., 1997) . Indeed, cells from these tumours have a hypermutator phenotype and the biochemical defect in the mismatch repair process was established (Bronner et al., 1994; Richards et al., 1997) . If inactivation of the OGG1 gene in mammalian cells also causes a mutator phenotype, it can be expected that cells lacking the Ogg1 activity could have enhanced possibility to undergo cancer transformation. The validation of this hypothesis requires the identi®cation of human tumours where both alleles of the OGG1 have been inactivated. A combination of cytogenetic and molecular studies have implicated loss of heterozygosity (LOH) or deletions in chromosome 3p in human lung and kidney cancers (Naylor et al., 1987; Yokota et al., 1987; Hibi et al., 1992) . Some of these rearrangements could aect the OGG1 gene which has been localised to 3p25-26 (Lu et al., 1997; Arai et al., 1997; Radicella et al., 1997; Roldan-Arjona et al., 1997; Bjoras et al., 1997) . Furthermore, the analysis of the sequence changes in the p53 tumour suppressor gene showed that in lung and kidney cancers there is a bias in favour of GC to TA tranversions (Hollstein et al., 1996) . This type of mutations would be expected in cells incapable of eliminating 8-OxoG from their DNA and therefore likely to be de®cient in the OGG1 gene.
For these reasons, we have analysed the expression of the OGG1 gene by RT ± PCR in a series human tumours composed of 25 small cell lung carcinomas and 15 kidney carcinomas. For renal carcinomas, the normal kidney tissue counterpart was also available for analysis. Examples of RT ± PCR products on an ethidium bromide stained gel are presented in Figure  1 . All clinical samples expressed OGG1 messenger RNA, nevertheless the lung carcinomas expressed OGG1 at a statistically higher level as compared to the renal carcinomas, the mean OGG1/b2 values being 1.08 and 0.232 (P50.0001, Student's t-test), respectively. On the other hand, no statistical dierence was noted in OGG1 messenger RNA expression between the tumoral and the normal kidney tissues, the mean OGG1/b2 values being 0.232 and 0.213 (P=0.52, Student's t-test), respectively. Similarly, measurement of OGG1 expression in a panel of 28 human lung cancer cell lines using Northern-blot analyses did not reveal cell lines showing undetectable level of OGG1 transcripts (Arai et al., 1997) .
To detect alterations of OGG1 in the same series of 40 human tumours, we have analysed the cDNAs using the DGGE method. A typical example of a DGGE electrophoretic pro®le is given in Figure 2 . Among the 25 small cell lung cancers and the 15 renal carcinomas, two and one tumours, respectively, have abnormal Figure 1 Example of semi-quantitative RT ± PCR analysis of human OGG1 gene expression in lung carcinomas and in tumour and normal kidney samples. OGG1 gene expression was detected by RT ± PCR and determined semi-quantitatively using b2 microglobulin (b2) as a reference housekeeping gene. RT was done according to the previously described protocol (Chevillard et al., 1996a) and PCR co-ampli®cation of both OGG1 and b2 was done in duplicate in the linear region of ampli®cation as function of the number of cycles and of the quantity of starting RNA (Chevillard et al., 1996a,b) . Upstream/reverse primers were 5'-GCGACTGCTGCGACAAGAC-3'/5'-TCGGGCACTGGCACT-CAC-3' and 5'-TACTCTCTCTTTCTGGCCTG-3'/5'-GACAAG-TCTGAATGCTCCAC-3', yielding 250 and 190 bp products for OGG1 and b2, respectively. PCR products were run at 100 volts in 2% agarose gels. The yield of PCR products was integrated for each sample, on digital video images of ethidium bromide stained gel using Image 1.44b11 Macintosh software and the OGG1/b2 ratio was calculated Figure 2 Examples of OGG1 DGGE pro®les of lung and kidney human tumours. OGG1 gene mutations were screened by DGGE analysis of RT ± PCR ampli®ed materials. Analysis of the cDNA melting domains, using the MacMeltTm software for Macintosh, showed that six independent RT ± PCR were mandatory to analyse the complete coding sequence. A psoralen clamp was attached at the 5' end of one of each set of primers. After PCR ampli®cations and formation of homo-and heteroduplexes (5' at 948C and 45' at 558C) stabilisation of duplexes was obtained by crosslinking both strands under UV irradiation (25 min at 365 nm) (Chevillard et al., 1997) . PCR products were then submitted to denaturant acrylamide gel electrophoresis. For each domain, the extent of the denaturant gradient (formamide, urea) and the length of migration were adjusted as a function of its Tm and of its size. Arbitrary homozygous mutant obtained by PCR ampli®cation using point-mutated primer (A), homozygous wild type (B) and heterozygous (a mixture of A and B products) (C) samples were systematically included as controls in each migration. After electrophoresis, gels were stained with ethidium bromide and photographed under UV illumination at 254 nm. The upper and lower parts of the ®gure show DGGE pro®les corresponding to domains spanning from nucleotides 651 ± 810 and 986 ± 1298, respectively. Lung 5 and kidney 4 show a clear one band pro®le, dierent from the wild type, indicating homozygous mutant pro®les electrophoretic patterns by DGGE as compared to the wild-type. The OGG1 domains showing an alteration in DGGE pro®le were independently ampli®ed by RT ± PCR and sequenced. The base changes observed in OGG1 cDNAs are described in Table 1 . All three are single base-pair substitutions; two transversions (GC to TA and TA to AT) and one transition (GC to AT). Furthermore, the three base substitutions detected in tumours cause missense mutations in the hOgg1 protein at codons 85, 131 and 232, respectively (Table 1) . To test the enzymatic activity, mutation of Arg 131 to Gln (R131Q) has been obtained after site directed mutagenesis of OGG1 cDNA. Mutation R131Q completely abolishes the capacity of the hOgg1 protein to repair 8-OxoG (data not shown). In all cases, the tumours were homozygous mutant, indicating most probably, a hemizygosity due to the loss of the wild type allele. Moreover, the normal renal tissue counterpart of the mutated kidney tumour was found to be homozygous wild-type for the expression of the OGG1 gene (data not shown). This last result suggests that inactivation of OGG1 in the tumour was the consequence of two somatic events following the classic pattern of tumour-suppressor gene inactivation: deletion of one allele and mutation of the other, or vice versa. It should be noticed that the three mutations occur in the region of hOgg1 that is common to both splicing products and consequently they alter both versions of the protein.
The repair of oxidative DNA damage is crucial to maintain the integrity of cellular DNA. The hOgg1 protein is an important enzyme that is proposed to counteract the mutagenic action of 8-OxoG occurring in DNA as a consequence of endogenous and exogenous oxidative stress. Consequently, it is reasonable to hypothesise that inactivation of OGG1 may generate a mutator phenotype that could enhance the initiation and the progression of the process of carcinogenesis. The identi®cation of missense mutations at OGG1 in 3 out of 40 lung and kidney human tumours is a ®rst step towards the demonstration that OGG1 is a new tumour suppressor gene. Nucleotide positions correspond to the cDNA sequence (accession # Y11731) where the ®rst ATG (starting coding sequence) is at position 339. Sequence analysis was carried out on independent RT ± PCR products of the three samples showing a DGGE pro®le dierent from the wild type (see Figure 2) 
